138 related articles for article (PubMed ID: 25166437)
21. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
Solomon A; Frangione B; Franklin EC
J Clin Invest; 1982 Aug; 70(2):453-60. PubMed ID: 6808027
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of serum free light chain in patients with multiple myeloma].
Zhang SS; Wu S; Qu XY; Xu J; Liu P; Lu H; Wu HX; Xu JR; Li JY; Chen LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):930-5. PubMed ID: 23998588
[TBL] [Abstract][Full Text] [Related]
23. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin free light chain dimers in human diseases.
Kaplan B; Livneh A; Sela BA
ScientificWorldJournal; 2011 Mar; 11():726-35. PubMed ID: 21442150
[TBL] [Abstract][Full Text] [Related]
26. Diversity and diversification of light chains in myeloma: the specter of amyloidogenesis by proxy.
Gu M; Wilton R; Stevens FJ
Contrib Nephrol; 2007; 153():156-81. PubMed ID: 17075229
[TBL] [Abstract][Full Text] [Related]
27. Light chain myeloma: A brief report from India.
Singh N; Agrawal N; Sekhri R; Mehta A; Kumar D; Vishwakarma G; Ahmed R; Bhurani D
Indian J Pathol Microbiol; 2019; 62(3):441-444. PubMed ID: 31361235
[TBL] [Abstract][Full Text] [Related]
28. [Primary amyloidosis associated with kappa light chain myeloma].
Martins RG; Roncon-Albuquerque R; Cabral R; Frazão J; Von Hafe P
Acta Med Port; 2010; 23(2):281-4. PubMed ID: 20470479
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of measurement of free light chains].
Matsuda M
Rinsho Byori; 2010 Apr; 58(4):401-4. PubMed ID: 20496770
[TBL] [Abstract][Full Text] [Related]
30. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
[TBL] [Abstract][Full Text] [Related]
31. Serum-free light chains in HIV-associated lymphoma: no correlation with histology or prognosis.
Tittle V; Rayment M; Keeling E; Gabriel I; Yarranton H; Bower M
AIDS; 2015 Jun; 29(10):1201-4. PubMed ID: 26035320
[TBL] [Abstract][Full Text] [Related]
32. Serum free light chains and the risk of ESRD and death in CKD.
Haynes R; Hutchison CA; Emberson J; Dasgupta T; Wheeler DC; Townend JN; Landray MJ; Cockwell P
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2829-37. PubMed ID: 22034503
[TBL] [Abstract][Full Text] [Related]
33. [The prognostic value of baseline serum free light chain in cardiac amyloidosis].
Zhao L; Tian Z; Fang Q
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369
[TBL] [Abstract][Full Text] [Related]
34. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin synthesis in primary and myeloma amyloidosis.
Preud'homme JL; Ganeval D; Grünfeld JP; Striker L; Brouet JC
Clin Exp Immunol; 1988 Sep; 73(3):389-94. PubMed ID: 3145161
[TBL] [Abstract][Full Text] [Related]
36. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin light chain amyloidosis and the kidney.
Gertz MA; Lacy MQ; Dispenzieri A
Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
Andrei M; Wang JC
Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
[TBL] [Abstract][Full Text] [Related]
39. Immunofluorescence study of "non-idiopathic" renal amyloidosis.
Orfila C; Rakotoarivony J; Segonds A; Suc JM
Hum Pathol; 1983 Apr; 14(4):362-7. PubMed ID: 6403452
[TBL] [Abstract][Full Text] [Related]
40. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
Levinson SS
Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
